These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544 [TBL] [Abstract][Full Text] [Related]
3. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite. Zanghi G; Vaughan AM Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178 [TBL] [Abstract][Full Text] [Related]
4. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses. White M; Amino R; Mueller I Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251 [TBL] [Abstract][Full Text] [Related]
6. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival. Hulden L; Hulden L Malar J; 2011 Apr; 10():90. PubMed ID: 21496287 [TBL] [Abstract][Full Text] [Related]
7. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission. White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC Elife; 2014 Nov; 3():. PubMed ID: 25406065 [TBL] [Abstract][Full Text] [Related]
8. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. Chen N; Auliff A; Rieckmann K; Gatton M; Cheng Q J Infect Dis; 2007 Apr; 195(7):934-41. PubMed ID: 17330782 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses. Molina DM; Finney OC; Arevalo-Herrera M; Herrera S; Felgner PL; Gardner MJ; Liang X; Wang R Am J Trop Med Hyg; 2012 Sep; 87(3):460-9. PubMed ID: 22826492 [TBL] [Abstract][Full Text] [Related]
14. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections. Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044 [TBL] [Abstract][Full Text] [Related]
15. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure. Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895 [TBL] [Abstract][Full Text] [Related]
16. Genomic Analyses Reveal the Common Occurrence and Complexity of Popovici J; Friedrich LR; Kim S; Bin S; Run V; Lek D; Cannon MV; Menard D; Serre D mBio; 2018 Jan; 9(1):. PubMed ID: 29362233 [No Abstract] [Full Text] [Related]
17. In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites. Gural N; Mancio-Silva L; Miller AB; Galstian A; Butty VL; Levine SS; Patrapuvich R; Desai SP; Mikolajczak SA; Kappe SHI; Fleming HE; March S; Sattabongkot J; Bhatia SN Cell Host Microbe; 2018 Mar; 23(3):395-406.e4. PubMed ID: 29478773 [TBL] [Abstract][Full Text] [Related]
18. The march toward malaria vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [TBL] [Abstract][Full Text] [Related]
19. An Activation-Clearance Model for Plasmodium vivax Malaria. Mehra S; McCaw JM; Flegg MB; Taylor PG; Flegg JA Bull Math Biol; 2020 Feb; 82(2):32. PubMed ID: 32052192 [TBL] [Abstract][Full Text] [Related]